Receba uma resposta desta empresa empregadora
Seu currículo e carta de apresentação personalizados exatamente para o que estão contratando.
The National Institutes of Biotechnology Malaysia (NIBM) is seeking a Scientist (Immunologist) to join our team and lead vaccine immunology research and development efforts.
The role requires a PhD in immunology-related fields, strong background in immune mechanisms, hands-on immunological assay experience, and the ability to work independently in a regulated environment. Collaboration with MGVI and other partners is essential.
The National Institutes of Biotechnology Malaysia (NIBM) is seeking a motivated, dedicated, and experienced Scientist (Immunologist) to join our team.
The National Institutes of Biotechnology Malaysia (NIBM) was established on 27 January 2012 as a consortium of national biotechnology institutes under the Ministry of Science, Technology and Innovation (MOSTI). NIBM leads research, development, innovation, and commercialisation of modern biotechnology through its three institutes — the Malaysian Agro-Biotechnology Institute (ABI), the Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), and the Malaysia Genome and Vaccine Institute (MGVI).
The government of Malaysia has identified biotechnology as another potential area to be the engine of growth. In 2002, three interim laboratories - Genomic & Molecular Biology; Agro-Biotechnology; and Pharmaceuticals & Nutraceuticals were established to provide research infrastructure for the 8th Malaysia Plan for National Biotechnology Agenda led by the Biotechnology Cooperative Centres (BCCs).
In 2005, these laboratories were inaugurated as National Biotechnology Institutes to lead, coordinate and implement the national biotechnology agenda through research, development, innovation and commercialization (RDIC). The three National Biotechnology Institutes are:
Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPHARM)
Malaysia Genome and Vaccine Institute (MGVI)
In 2011, the institutes were restructured and placed under an autonomous organization called the National Institutes of Biotechnology Malaysia (NIBM). While the three institutes focus on high quality and market driven R&D and innovations, NIBM’s key role is to support and spearhead the commercialization of the R&D activities at the institutes based on industry requirements.
Application closing date: 24th August 2026.